Medication reference tables for neurologists: A focus on psychotropic medications in epilepsy

IF 1.5 Q3 CLINICAL NEUROLOGY
Heidi M. Munger Clary , Gaston Baslet , Gerardo Maria de Araujo Filho , David Dunn , Alexis Tarrada , Coraline Hingray , Andres M. Kanner
{"title":"Medication reference tables for neurologists: A focus on psychotropic medications in epilepsy","authors":"Heidi M. Munger Clary ,&nbsp;Gaston Baslet ,&nbsp;Gerardo Maria de Araujo Filho ,&nbsp;David Dunn ,&nbsp;Alexis Tarrada ,&nbsp;Coraline Hingray ,&nbsp;Andres M. Kanner","doi":"10.1016/j.ebr.2025.100760","DOIUrl":null,"url":null,"abstract":"<div><div>Many psychotropic medications are prescribed to people with epilepsy by neurologists and other non-neurology providers. This article presents summary tables with information on specific psychotropic drug classes (antidepressants, stimulant medications, and antipsychotic medications) including initiation schedules, dosing and indication. Given the overall paucity of epilepsy specific data available, the information is based primarily on regulatory approvals or other general population data, along with unique considerations for epilepsy such as interactions with antiseizure medications. While information is presented across the age span for antidepressants and stimulants, information on antipsychotic medications is focused on the most commonly prescribed medications for adults with psychotic episodes or acutely agitated states. Summary information on psychiatric and cognitive side effects of antiseizure medications and psychotropic benefits of antiseizure medications are also presented. This article is intended to provide a handy reference to neurologists involved in managing mental health in a clinical setting or caring for patients already receiving psychotropic medications for mental health comorbidities. This article provides an overview of a more comprehensive list of psychotropic medications than the case-based articles of the special issue and is intended to supplement the focused and practical information presented in the other articles.</div></div>","PeriodicalId":36558,"journal":{"name":"Epilepsy and Behavior Reports","volume":"30 ","pages":"Article 100760"},"PeriodicalIF":1.5000,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Epilepsy and Behavior Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2589986425000206","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Many psychotropic medications are prescribed to people with epilepsy by neurologists and other non-neurology providers. This article presents summary tables with information on specific psychotropic drug classes (antidepressants, stimulant medications, and antipsychotic medications) including initiation schedules, dosing and indication. Given the overall paucity of epilepsy specific data available, the information is based primarily on regulatory approvals or other general population data, along with unique considerations for epilepsy such as interactions with antiseizure medications. While information is presented across the age span for antidepressants and stimulants, information on antipsychotic medications is focused on the most commonly prescribed medications for adults with psychotic episodes or acutely agitated states. Summary information on psychiatric and cognitive side effects of antiseizure medications and psychotropic benefits of antiseizure medications are also presented. This article is intended to provide a handy reference to neurologists involved in managing mental health in a clinical setting or caring for patients already receiving psychotropic medications for mental health comorbidities. This article provides an overview of a more comprehensive list of psychotropic medications than the case-based articles of the special issue and is intended to supplement the focused and practical information presented in the other articles.
神经科医生用药参考表:癫痫的精神药物的焦点
许多精神药物是由神经科医生和其他非神经科医生开给癫痫患者的。这篇文章提供了关于特定精神药物类别(抗抑郁药、兴奋剂和抗精神病药物)的信息汇总表,包括起始时间表、剂量和适应症。鉴于现有的癫痫相关数据总体上缺乏,这些信息主要基于监管机构批准或其他一般人群数据,以及对癫痫的独特考虑,如与抗癫痫药物的相互作用。虽然抗抑郁药和兴奋剂的信息是跨年龄的,但抗精神病药物的信息主要集中在患有精神病发作或急性激动状态的成年人最常用的处方药上。本文还介绍了抗癫痫药物对精神和认知方面的副作用以及抗癫痫药物对精神方面的益处。这篇文章的目的是提供一个方便的参考神经科医生参与管理精神健康在临床设置或照顾病人已经接受精神药物治疗精神健康合并症。这篇文章提供了一个更全面的精神药物清单的概述,而不是以病例为基础的特刊文章,旨在补充其他文章中提出的重点和实用信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Epilepsy and Behavior Reports
Epilepsy and Behavior Reports Medicine-Neurology (clinical)
CiteScore
2.70
自引率
13.30%
发文量
54
审稿时长
50 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信